CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Predictive Oncology Inc. - POAI CFD

2.53
8.33%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.10
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 2.76
Open* 2.74
1-Year Change* 568.29%
Day's Range* 2.53 - 2.74
52 wk Range 2.47-13.88
Average Volume (10 days) 14.70K
Average Volume (3 months) 358.54K
Market Cap 11.05M
P/E Ratio -100.00K
Shares Outstanding 4.06M
Revenue 1.81M
EPS -4.64
Dividend (Yield %) N/A
Beta 1.29
Next Earnings Date Mar 19, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 28, 2024 2.53 -0.21 -7.66% 2.74 2.74 2.53
Mar 27, 2024 2.76 0.09 3.37% 2.67 2.76 2.57
Mar 26, 2024 2.64 0.01 0.38% 2.63 2.65 2.52
Mar 25, 2024 2.59 0.06 2.37% 2.53 2.72 2.52
Mar 22, 2024 2.52 -0.01 -0.40% 2.53 2.61 2.43
Mar 21, 2024 2.56 0.01 0.39% 2.55 2.66 2.53
Mar 20, 2024 2.55 -0.01 -0.39% 2.56 2.56 2.53
Mar 19, 2024 2.57 0.00 0.00% 2.57 2.61 2.57
Mar 18, 2024 2.68 0.07 2.68% 2.61 2.75 2.55
Mar 15, 2024 2.54 -0.05 -1.93% 2.59 2.65 2.44
Mar 14, 2024 2.60 -0.34 -11.56% 2.94 2.94 2.59
Mar 13, 2024 2.83 -0.01 -0.35% 2.84 3.05 2.78
Mar 12, 2024 2.83 -0.05 -1.74% 2.88 2.94 2.81
Mar 11, 2024 2.88 -0.05 -1.71% 2.93 2.94 2.80
Mar 8, 2024 2.88 0.04 1.41% 2.84 2.98 2.84
Mar 7, 2024 2.83 0.03 1.07% 2.80 2.85 2.77
Mar 6, 2024 2.79 -0.09 -3.12% 2.88 2.95 2.74
Mar 5, 2024 2.85 -0.05 -1.72% 2.90 2.93 2.78
Mar 4, 2024 2.94 -0.04 -1.34% 2.98 3.00 2.88
Mar 1, 2024 2.98 -0.09 -2.93% 3.07 3.13 2.97

Predictive Oncology Inc. Events

Time (UTC) Country Event
Monday, April 1, 2024

Time (UTC)

12:30

Country

US

Event

Q4 2023 Predictive Oncology Inc Earnings Call
Q4 2023 Predictive Oncology Inc Earnings Call

Forecast

-

Previous

-
Thursday, April 18, 2024

Time (UTC)

20:00

Country

US

Event

Predictive Oncology Inc Annual Shareholders Meeting
Predictive Oncology Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Monday, May 13, 2024

Time (UTC)

10:59

Country

US

Event

Q1 2024 Predictive Oncology Inc Earnings Release
Q1 2024 Predictive Oncology Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 1.50546 1.42068 1.25227 1.41157 1.41166
Revenue 1.50546 1.42068 1.25227 1.41157 1.41166
Cost of Revenue, Total 0.50511 0.48702 0.44719 0.53181 0.41576
Gross Profit 1.00035 0.93366 0.80508 0.87976 0.9959
Total Operating Expense 27.5391 21.8493 28.609 24.6374 9.27303
Selling/General/Admin. Expenses, Total 12.4696 11.7067 10.9369 11.6941 6.99615
Interest Expense (Income) - Net Operating
Other Operating Expenses, Total 3.79843 2.69857 2.35171 2.96013 1.86112
Operating Income -26.0336 -20.4286 -27.3567 -23.2258 -7.86137
Net Income Before Taxes -25.7376 -20.3188 -25.8844 -19.3908 -10.0865
Net Income After Taxes -25.7376 -19.6572 -25.8844 -19.3908 -10.0865
Net Income Before Extra. Items -25.7376 -19.6572 -25.8844 -19.3908 -10.0865
Net Income -25.7376 -19.6572 -25.8844 -19.3908 -10.0865
Income Available to Common Excl. Extra. Items -25.7376 -19.6572 -26.4387 -19.6807 -10.0865
Income Available to Common Incl. Extra. Items -25.7376 -19.6572 -26.4387 -19.6807 -10.0865
Diluted Net Income -25.7376 -19.6572 -26.4387 -19.6807 -10.0865
Diluted Weighted Average Shares 3.6499 2.7438 0.59751 0.14351 0.06408
Diluted EPS Excluding Extraordinary Items -7.0516 -7.16421 -44.2483 -137.141 -157.401
Diluted Normalized EPS -4.10195 -5.5161 -19.3562 -71.2816 -157.401
Interest Income (Expense), Net Non-Operating 0.11565 0.1649 3.05591 5.72462 -2.29358
Other, Net 0.18037 -0.0551 -1.58359 -1.88957 0.06848
Total Adjustments to Net Income 0 -0.55429 -0.28994
Unusual Expense (Income) 10.7659 6.95707 14.8732 9.45132
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 0.49011 0.2399 0.36347 0.45583 0.37159
Revenue 0.49011 0.2399 0.36347 0.45583 0.37159
Cost of Revenue, Total 0.15976 0.12014 0.15344 0.10815 0.13408
Gross Profit 0.33035 0.11976 0.21003 0.34768 0.23751
Total Operating Expense 4.44934 3.70488 8.3269 4.58658 10.897
Selling/General/Admin. Expenses, Total 3.1266 2.69956 3.49751 3.6213 2.62272
Other Operating Expenses, Total 0.99304 0.87852 1.14111 0.85713 0.90911
Operating Income -3.95923 -3.46498 -7.96343 -4.13075 -10.5254
Interest Income (Expense), Net Non-Operating 0.00731 0.00095 0.00827 0.01022 0.09525
Other, Net 0.02855 0.04223 0.03905 0.06105 0.03883
Net Income Before Taxes -3.92337 -3.4218 -7.91611 -4.05948 -10.3913
Net Income After Taxes -3.92337 -3.4218 -7.91611 -4.05948 -10.3913
Net Income Before Extra. Items -3.92337 -3.4218 -7.91611 -4.05948 -10.3913
Net Income -3.92337 -3.4218 -7.91611 -4.05948 -10.3913
Income Available to Common Excl. Extra. Items -3.92337 -3.4218 -7.91611 -4.05948 -10.3913
Income Available to Common Incl. Extra. Items -3.92337 -3.4218 -7.91611 -4.05948 -10.3913
Diluted Net Income -3.92337 -3.4218 -7.91611 -4.05948 -10.3913
Diluted Weighted Average Shares 3.99651 3.9681 3.93693 3.91919 3.44483
Diluted EPS Excluding Extraordinary Items -0.9817 -0.86233 -2.01073 -1.0358 -3.0165
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.94094 -0.86233 -1.11286 -1.0358 -0.91738
Unusual Expense (Income) 0.16291 3.53484 0 7.23109
Total Adjustments to Net Income
Depreciation / Amortization 0.00704 0.00667
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 23.36 29.4583 1.51424 0.79826 1.45153
Cash and Short Term Investments 22.0715 28.2026 0.67833 0.15083 0.16215
Cash 22.0715 28.2026 0.67833 0.15083 0.16215
Short Term Investments 0
Total Receivables, Net 0.3312 0.3542 0.25688 0.29706 0.72988
Accounts Receivable - Trade, Net 0.3312 0.3542 0.25688 0.29706 0.2326
Total Inventory 0.43049 0.38768 0.28954 0.19016 0.24107
Prepaid Expenses 0.5268 0.51378 0.28949 0.16022 0.31843
Total Assets 25.7346 43.7713 13.0604 22.3755 3.709
Property/Plant/Equipment, Total - Net 2.04515 3.32603 5.21805 2.23754 0.18045
Intangibles, Net 0.25387 3.96212 3.3981 3.64941 0.9645
Total Current Liabilities 3.88267 3.24051 9.33692 10.8739 3.65553
Accounts Payable 0.94345 1.02177 1.37207 3.15564 0.44569
Accrued Expenses 2.32331 1.9023 3.18552 2.83111 1.27911
Notes Payable/Short Term Debt 0 0 0 4.7958 1.63491
Other Current Liabilities, Total 0.61591 0.31643 0.34741 0.09137 0.29581
Total Liabilities 3.96875 3.50559 10.4178 11.1442 3.65553
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0.08608 0.26508 1.08083 0.27026
Total Equity 21.7659 40.2657 2.64268 11.2313 0.05347
Preferred Stock - Non Redeemable, Net 0.00079 0.00079 0.00079 0.0358 0.00079
Common Stock 0.78763 0.65615 0.19805 0.04057 0.14092
Additional Paid-In Capital 174.755 167.649 110.827 93.6537 63.0197
Retained Earnings (Accumulated Deficit) -153.778 -128.04 -108.383 -82.4987 -63.1079
Other Equity, Total
Total Liabilities & Shareholders’ Equity 25.7346 43.7713 13.0604 22.3755 3.709
Total Common Shares Outstanding 3.93814 3.28073 0.99024 0.20283 0.07046
Total Preferred Shares Outstanding 0.07925 0.07925 0.07925 3.5795 0.07925
Note Receivable - Long Term 0 1.11252
Property/Plant/Equipment, Total - Gross 4.92275 5.39436 6.5499 3.00912
Accumulated Depreciation, Total -2.8776 -2.06834 -1.33185 -0.77157
Goodwill, Net 0 6.85779 2.81379 15.6903
Other Long Term Assets, Total 0.07562 0.16707 0.11626
Current Port. of LT Debt/Capital Leases 0 4.43193
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 13.5205 15.9695 19.7802 23.36 26.8573
Cash and Short Term Investments 11.915 14.7638 18.5971 22.0715 25.3937
Cash 11.915 14.7638 18.5971 22.0715 25.3937
Total Receivables, Net 0.54476 0.43085 0.28276 0.3312 0.32471
Accounts Receivable - Trade, Net 0.54476 0.43085 0.28276 0.3312 0.32471
Total Inventory 0.43999 0.3937 0.38029 0.43049 0.49372
Prepaid Expenses 0.62069 0.38123 0.52001 0.5268 0.64515
Total Assets 18.1669 20.967 25.0616 25.7346 33.1662
Property/Plant/Equipment, Total - Net 4.26297 4.5572 4.83434 2.04515 2.53167
Property/Plant/Equipment, Total - Gross 7.69956 7.83767 7.9417 4.92275 5.24453
Accumulated Depreciation, Total -3.43659 -3.28047 -3.10737 -2.8776 -2.71287
Goodwill, Net 0 0
Intangibles, Net 0.25932 0.26618 0.27297 0.25387 3.7016
Other Long Term Assets, Total 0.1241 0.1741 0.1741 0.07562 0.07562
Total Current Liabilities 4.17189 3.76334 3.91035 3.88267 3.46808
Accounts Payable 1.16823 1.01348 1.42448 0.94345 0.91727
Accrued Expenses 2.36638 2.11639 1.83375 2.32331 2.03334
Notes Payable/Short Term Debt 0.26022 0 0 0 0
Other Current Liabilities, Total 0.37707 0.63347 0.65212 0.61591 0.51746
Total Liabilities 6.51551 6.26195 6.50719 3.96875 3.57333
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 2.34362 2.49861 2.59685 0.08608 0.10525
Total Equity 11.6514 14.7051 18.5544 21.7659 29.5929
Preferred Stock - Non Redeemable, Net 0.00079 0.00079 0.00159 0.00079 0.00079
Common Stock 0.04033 0.04006 0.0397 0.78763 0.78407
Additional Paid-In Capital 175.897 175.787 175.713 174.755 174.67
Retained Earnings (Accumulated Deficit) -164.287 -161.123 -157.2 -153.778 -145.862
Total Liabilities & Shareholders’ Equity 18.1669 20.967 25.0616 25.7346 33.1662
Total Common Shares Outstanding 4.03329 4.0063 3.96999 3.93814 3.92037
Total Preferred Shares Outstanding 0.07925 0.07925 0.07925 0.07925 0.07925
Current Port. of LT Debt/Capital Leases
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -25.7376 -19.6572 -25.8844 -19.3908 -10.0865
Cash From Operating Activities -12.3708 -12.2089 -12.2577 -8.73245 -5.28796
Cash From Operating Activities 1.31308 1.3403 1.02485 0.70488 0.14763
Non-Cash Items 11.1871 7.30233 13.8147 8.07998 3.76659
Cash Interest Paid 0.00382 0.69051 0.14583
Changes in Working Capital 0.86669 -1.19438 -1.21288 1.87345 0.8843
Cash From Investing Activities -0.4757 -10.6075 -0.16746 -0.59909 -1.11065
Capital Expenditures -0.4757 -0.96232 -0.36078 -0.02661 -0.232
Other Investing Cash Flow Items, Total 0 -9.64521 0.19332 -0.57248 -0.87865
Cash From Financing Activities 6.71541 50.3408 12.9527 9.32022 5.79457
Issuance (Retirement) of Stock, Net 6.71541 55.7015 11.8851 7.98702 3.60957
Issuance (Retirement) of Debt, Net 0 1.28948 1.53549 2.185
Net Change in Cash -6.13109 27.5243 0.5275 -0.01132 -0.60404
Financing Cash Flow Items 0 -5.36071 -0.22191 -0.20229
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -3.4218 -25.7376 -17.8215 -13.762 -3.37072
Cash From Operating Activities -3.42776 -12.3708 -9.13581 -6.42781 -3.0937
Cash From Operating Activities 0.23785 1.31308 0.98038 0.64944 0.3236
Non-Cash Items 0.02035 11.1871 7.5351 7.42432 0.19793
Changes in Working Capital -0.26416 0.86669 0.17023 -0.73953 -0.24452
Cash From Investing Activities -0.04664 -0.4757 -0.4121 -0.26842 -0.08024
Capital Expenditures -0.04664 -0.4757 -0.4121 -0.26842 -0.08024
Cash From Financing Activities 0 6.71541 6.73903 6.74306 0.08689
Financing Cash Flow Items 0 0 0 0
Issuance (Retirement) of Stock, Net 0 6.71541 6.73903 6.74306 0.08689
Net Change in Cash -3.4744 -6.13109 -2.80888 0.04684 -3.08705
Cash Interest Paid 0.00382 0.00375 0.00144
Issuance (Retirement) of Debt, Net
Other Investing Cash Flow Items, Total 0

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Predictive Oncology Inc. Company profile

Predictive Oncology Inc. provides various healthcare products and services primarily in the United States. The company operates in three segments: Helomics, Soluble, and Skyline. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers STREAMWAY System, a wall-mounted fully automated system that disposes suction fluid providing uninterrupted performance for physicians while virtually eliminating healthcare workers'' exposure to infectious fluids collected during surgical and other patient procedures, as well as proprietary cleaning fluid and filters to users of its systems. The company also provides contract research organization (CRO) and AI-driven predictive models of tumor drug response to improve clinical outcomes to assist pharmaceutical, diagnostic, and biotech industries; and soluble and stable formulations for proteins, including vaccines, antibodies, and other protein therapeutics, as well as develops tumor models for precision cancer therapy and drug development. Its CRO services enhance the effectiveness of cancer therapy using the power of artificial intelligence (AI) applied to diseases databases. The company sells its medical device products directly to hospitals and other medical facilities through employed sales representatives, independent contractors, and distributors. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.
Industry: Medical Equipment, Supplies & Distribution (NEC)

2915 Commers Dr Ste 900
EAGAN
MINNESOTA 55121-2363
US

Income Statement

  • Annual
  • Quarterly

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

Gold

2,233.43 Price
+1.740% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 21:00 (UTC)
Spread 0.80

XRP/USD

0.63 Price
-1.420% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,543.77 Price
-0.570% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

BTC/USD

69,988.60 Price
-1.120% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading